ScholarIQanswers from OpenAlex & ORCID
Ferdinand C. Breedveld
ResearcherPublications, citations & collaboration network
Ferdinand C. Breedveld is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ferdinand C. Breedveld have?
ScholarIQindexed works
Ferdinand C. Breedveld has 224 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ferdinand C. Breedveld have?
ScholarIQcitation count
Ferdinand C. Breedveld has 34,153 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ferdinand C. Breedveld?
ScholarIQh-index
Ferdinand C. Breedveld has an h-index of 79 in OpenAlex.
What is the i10-index of Ferdinand C. Breedveld?
ScholarIQi10-index
Ferdinand C. Breedveld has an i10-index of 167 in OpenAlex.
What is the OpenAlex record for Ferdinand C. Breedveld?
ScholarIQopenalex
The OpenAlex for Ferdinand C. Breedveld is on the source record.
What are the most-cited papers on Ferdinand C. Breedveld?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Diana Davis, J. D. Macfarlane, Christian Antoni, Burkhard F. Leeb, Michael J. Elliott, James N. Woody, T Schaible, Marc Feldmann
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Simone Gorter, Rachel Knevel, J. Nam, Monika Schoels, Daniel Aletaha, Maya H Buch, Laure Gossec, T. Huizinga, J. W. J. Bijlsma, Gerd R Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan J. Gómez‐Reino, Marios Kouloumas, Tore K Kvien, E. Martín‐Mola, Iain B. McInnes, Karel Pavelká, Piet L. C. M. van Riel, M. Scholte, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin Winthrop, John B. Wong, A. Zink, Désirée van der Heijde